• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过自发形成的离子液体纳米复合物实现索拉非尼的口服递送。

Oral delivery of sorafenib through spontaneous formation of ionic liquid nanocomplexes.

机构信息

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, United States; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China.

John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA 02138, United States; Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, United States.

出版信息

J Control Release. 2020 Jun 10;322:602-609. doi: 10.1016/j.jconrel.2020.03.018. Epub 2020 Mar 19.

DOI:10.1016/j.jconrel.2020.03.018
PMID:32201308
Abstract

Delivery of hydrophobic drugs is a significant challenge due to poor solubility and formulation difficulty. Here, we describe the potential of ionic liquids, in particular choline and geranic acid (CAGE), for oral delivery of a hydrophobic drug, sorafenib (SRF). CAGE provided excellent apparent solubility of SRF tosylate (> 500 mg/mL). Upon oral dosing in rats, CAGE increased peak blood concentrations of SRF by 2.2-fold. The elimination half-life of SRF was also increased by 2-fold and the mean absorption time was extended by 1.6-fold. Furthermore, SRF delivered by CAGE exhibited significantly different biodistribution compared to control formulations. Specifically, accumulation in lungs and kidneys improved 4.4-fold and 6.2-fold, respectively compared to control formulations. Mechanistic studies revealed that SRF-CAGE solution spontaneously formed a self-assembled structure (427 ± 41 nm), which is likely responsible for altered biodistribution in vivo. UPLC-MS studies confirmed the presence of choline-geranate species in blood indicative of micellar/emulsion structures which eventually dissociated into choline and geranic acid molecular species. These studies provide a simple, scalable strategy for oral delivery of hydrophobic drugs.

摘要

由于疏水性药物溶解度差和制剂困难,其传递是一个重大挑战。在这里,我们描述了离子液体(特别是胆碱和香叶酸(CAGE))在将疏水性药物索拉非尼(SRF)经口递送给的潜在应用。CAGE 为 SRF 对甲苯磺酸盐提供了极好的表观溶解度(> 500mg/mL)。在大鼠口服给药后,CAGE 将 SRF 的血药峰浓度提高了 2.2 倍。SRF 的消除半衰期也增加了 2 倍,平均吸收时间延长了 1.6 倍。此外,与对照制剂相比,CAGE 递送的 SRF 表现出明显不同的生物分布。具体而言,与对照制剂相比,肺和肾脏中的积累分别提高了 4.4 倍和 6.2 倍。机制研究表明,SRF-CAGE 溶液自发形成自组装结构(427±41nm),这可能是体内改变生物分布的原因。UPLC-MS 研究证实了血液中存在胆碱-香叶酸盐,表明存在胶束/乳剂结构,最终这些结构解离为胆碱和香叶酸分子。这些研究为疏水性药物的经口传递提供了一种简单、可扩展的策略。

相似文献

1
Oral delivery of sorafenib through spontaneous formation of ionic liquid nanocomplexes.通过自发形成的离子液体纳米复合物实现索拉非尼的口服递送。
J Control Release. 2020 Jun 10;322:602-609. doi: 10.1016/j.jconrel.2020.03.018. Epub 2020 Mar 19.
2
Enhancement of Anticancer Efficacy and Tumor Penetration of Sorafenib by Ionic Liquids.离子液体增强索拉非尼的抗癌疗效及肿瘤穿透性
Adv Healthc Mater. 2021 Jan;10(2):e2001455. doi: 10.1002/adhm.202001455. Epub 2020 Nov 17.
3
Favipiravir-Based Ionic Liquids as Potent Antiviral Drugs for Oral Delivery: Synthesis, Solubility, and Pharmacokinetic Evaluation.基于法匹拉韦的离子液体作为口服递送的强效抗病毒药物:合成、溶解度和药代动力学评价。
Mol Pharm. 2021 Aug 2;18(8):3108-3115. doi: 10.1021/acs.molpharmaceut.1c00324. Epub 2021 Jul 10.
4
Methotrexate-based ionic liquid as a potent anticancer drug for oral delivery: In vivo pharmacokinetics, biodistribution, and antitumor efficacy.基于甲氨蝶呤的离子液体作为一种有效的口服抗癌药物:体内药代动力学、生物分布和抗肿瘤疗效。
Int J Pharm. 2021 Oct 25;608:121129. doi: 10.1016/j.ijpharm.2021.121129. Epub 2021 Sep 22.
5
Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.将难溶性药物转化为亲脂性离子液体可提高基于脂质制剂的口服药物暴露量。
Mol Pharm. 2015 Jun 1;12(6):1980-91. doi: 10.1021/mp500790t. Epub 2015 May 5.
6
The molecular mechanism behind the stabilization of insulin by choline and geranate (CAGE) ionic liquids - computational insights into oral insulin drug formulation.胆碱和格尔酸(CAGE)离子液体稳定胰岛素的分子机制 - 口服胰岛素药物制剂的计算见解。
Phys Chem Chem Phys. 2021 Nov 17;23(44):25298-25307. doi: 10.1039/d1cp03349b.
7
Ionic liquids for oral insulin delivery.用于口服胰岛素传递的离子液体。
Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7296-7301. doi: 10.1073/pnas.1722338115. Epub 2018 Jun 25.
8
Choline and geranic acid (CAGE) ionic liquids inhibit both elastase activity and growth of oral bacteria.胆碱与香叶酸(CAGE)离子液体可抑制弹性蛋白酶活性及口腔细菌生长。
J Biomed Mater Res A. 2023 May;111(5):682-687. doi: 10.1002/jbm.a.37485. Epub 2022 Dec 24.
9
Mucoadhesive Ionic Liquid Gel Patches for Oral Delivery.用于口服给药的粘膜粘附型离子液体凝胶贴片
ACS Biomater Sci Eng. 2023 Jun 12;9(6):2838-2845. doi: 10.1021/acsbiomaterials.0c01024. Epub 2020 Sep 3.
10
Transdermal delivery of nobiletin using ionic liquids.利用离子液体经皮递送川陈皮素。
Sci Rep. 2019 Dec 27;9(1):20191. doi: 10.1038/s41598-019-56731-1.

引用本文的文献

1
Hydrophobicity-Driven Enhancement of Hydrogen Bonding in Ionic Liquid Hybrid Solvents.离子液体混合溶剂中疏水性驱动的氢键增强作用。
J Phys Chem B. 2025 Jul 17;129(28):7228-7237. doi: 10.1021/acs.jpcb.5c01687. Epub 2025 Jul 4.
2
Host-Derived Geranylgeraniol Shields Intraerythrocytic Stages of Malaria Parasites from Fosmidomycin.宿主来源的香叶基香叶醇可保护疟原虫的红细胞内期免受磷霉素的影响。
Res Sq. 2025 Jun 5:rs.3.rs-6574048. doi: 10.21203/rs.3.rs-6574048/v1.
3
An Overview on the Role of Ionic Liquids and Deep Eutectic Solvents in Oral Pharmaceuticals.
离子液体和低共熔溶剂在口服药物中的作用概述
Pharmaceutics. 2025 Feb 25;17(3):300. doi: 10.3390/pharmaceutics17030300.
4
Ionic Liquid-Mediated Transdermal Delivery of Organogel Containing Cyclosporine A for the Effective Treatment of Psoriasis.离子液体介导含环孢素 A 的有机凝胶经皮给药用于银屑病的有效治疗
ACS Omega. 2024 Sep 25;9(40):41565-41582. doi: 10.1021/acsomega.4c05346. eCollection 2024 Oct 8.
5
Unnatural Amino Acid-Based Ionic Liquid Enables Oral Treatment of Nonsense Mutation Disease in Mice.基于非天然氨基酸的离子液体可实现对小鼠无义突变疾病的口服治疗。
Adv Sci (Weinh). 2024 Apr;11(13):e2306792. doi: 10.1002/advs.202306792. Epub 2024 Jan 30.
6
Potentials of ionic liquids to overcome physical and biological barriers.离子液体克服物理和生物屏障的潜力。
Adv Drug Deliv Rev. 2024 Jan;204:115157. doi: 10.1016/j.addr.2023.115157. Epub 2023 Dec 15.
7
Development of ionic liquid-coated PLGA nanoparticles for applications in intravenous drug delivery.聚乳酸-乙醇酸共聚物纳米粒载药系统的静脉给药应用研究进展
Nat Protoc. 2023 Aug;18(8):2509-2557. doi: 10.1038/s41596-023-00843-6. Epub 2023 Jul 19.
8
Recent Advances in Biocompatible Ionic Liquids in Drug Formulation and Delivery.生物相容性离子液体在药物制剂与给药中的最新进展
Pharmaceutics. 2023 Apr 7;15(4):1179. doi: 10.3390/pharmaceutics15041179.
9
Translation of ionic liquids to be enteric nanoparticles for facilitating oral absorption of cyclosporine A.将离子液体转化为肠溶纳米颗粒以促进环孢素A的口服吸收。
Bioeng Transl Med. 2022 Sep 7;8(2):e10405. doi: 10.1002/btm2.10405. eCollection 2023 Mar.
10
Deep Eutectic Systems as Novel Vehicles for Assisting Drug Transdermal Delivery.低共熔体系作为辅助药物透皮给药的新型载体
Pharmaceutics. 2022 Oct 23;14(11):2265. doi: 10.3390/pharmaceutics14112265.